(17) Encourages a More Effective Breakdown of Alcohol In an experimental study on rats exposed to alcohol, administration of glutathione enhanced the activity of key alcoholmetabolizing enzymes, such as: Alcohol dehydrogenase (ADH) Aldehyde dehydrogenase (ALDH) As we know, these enzymes are central to converting ethanol to acetaldehyde and then to the less toxic acetate, via alcohol metabolism pathways in the liver
In the trial, dose escalation occurred every 4 weeks from 0.25 mg at baseline to 2.4 mg at the end of the escalation period
The diagnosis of Parkinson's disease
By providing a robust intracellular antioxidant shield, glutathione helps stabilize hyper-reactive mast cells, making them less likely to release histamine in response to minor environmental triggers, thereby reducing the frequency of hives, flushing, and sudden allergic responses
Areas Without Adequate Human Evidence Long-term cardiovascular safety Long-term neurological safety Endocrine effects beyond selected hormone measurements Effects on glucose regulation in people Immune responses Allergic reactions Genotoxicity Carcinogenicity Effects in people with cancer or precancerous disease Reproductive and developmental toxicity Pregnancy safety Breastfeeding safety Paediatric exposure Medicine interactions Interaction with hormone or sleep treatments Repeated exposure over months or years Product-Quality Risks Incorrect amino-acid sequence Glu and Asp residue-order errors Wrong terminal groups Incorrect free-base or acetate designation Incorrect peptide quantity Deletion-sequence impurities Incomplete deprotection Residual synthesis reagents Residual solvents Peptide aggregates Degradation during transport or storage Unverified microbiological quality Unverified bacterial-endotoxin control Certificates unrelated to the supplied batch No reports does not mean no risk FDAs adverse-event database search found no Epitalon reports through December 2025
